The Pharmaceutical Journal
Vol 273 No 7320 p506
9 October 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Immunoglobulin in MS

Intravenous immunoglobulin cannot be recommended for patients with secondary progressive multiple sclerosis, say researchers. Patients were randomised to IV immunoglobulin or placebo, but no differences in clinical outcome measures were observed (Lancet 2004;364:1149).